NCT05949424 2023-11-29
OPTI-DOSE
University Medical Center Groningen
Phase 4 Unknown
Clinical Trials
4 trialsNCT01706120 2023-03-24
MITO16/MANGO-2
National Cancer Institute, Naples
Phase 4 Unknown
NCT05187208 2022-01-26
POLO
Seoul National University Hospital
Phase 4 Unknown
NCT03475589 2020-05-12
Study on the Adverse Drug Reactions (ADRs) of Apatinib and Their Biomarker Correlations
Sun Yat-sen University
Phase 4 Unknown